Infant acute lymphoblastic leukemia: A 20-year children's hospital experience

Fetal and Pediatric Pathology

Volumn 27, Issue 4-5, 2008, Pages 197-205

  Murray, Rebecca A F ^a   Thom, Giddel ^a   Gardner, Renee V ^a   Craver, Randall D ^a,b  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL   (United States)

Author keywords

Acute lymphoblastic leukemia (ALL); Infant; Mixed lineage leukemia gene

Indexed keywords

ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; GRANULOCYTE COLONY STIMULATING FACTOR; HYDROCORTISONE; IMMUNOGLOBULIN; METHOTREXATE; MIXED LINEAGE LEUKEMIA PROTEIN; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; CENTRAL NERVOUS SYSTEM DISEASE; CHROMOSOME 11Q; CHROMOSOME ABERRATION; CYTOGENETICS; DIPLOIDY; FEMALE; HEPATOSPLENOMEGALY; HUMAN; INFANT; INTESTINE TRANSPLANTATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PEDIATRIC HOSPITAL; PRIORITY JOURNAL; REVIEW; STEM CELL TRANSPLANTATION;

ACUTE DISEASE; CHROMOSOMES, HUMAN, PAIR 11; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITALS, UNIVERSITY; HUMANS; INFANT; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME;

EID: 52149085207     PISSN: 15513815     EISSN: 15513823     Source Type: Journal    
DOI: 10.1080/15513810802319392     Document Type: Review

References (15)

1. Stam RW, Boer ML, Pieters R. Towards targeted therapy for infant acute lymphoblastic leukaemia. Br J Haematol 132:539-551, 2006.
2. Leiper AD, Chessells J. Acute lymphoblastic leukaemia under 2 years. Arch Dis Child 61:1007-1012, 1986.
3. Stam RW, den Boer ML, Passier MM, et al. Silencing of the tumor suppressor gene FHIT is highly characteristic for MLL gene rearranged infant acute lymphoblastic leukemia. Leukemia 20:264-271, 2006.
4. Pui CH, Ribeiro RC, Campana D, et al. Prognostic factors in the acute lymphoid and myeloid leukemias of infants. Leukemia 10:952-956, 1996.
5. Crist W, Pullen J, Boyett J, et al. Clinical and biologic features predict a poor prognosis in acute lymphoid leukemias in infants: a Pediatric Oncology Group Study. Blood 67:135-140, 1986.
6. Stark B, Vogel R, Cohen IJ, et al. Biologic and cytogenetic characteristics of leukemia in infants. Cancer 63:117-125, 1989.
7. Kosaka Y, Koh K, Kinukawa N, et al. Infant acute lymphoblastic leukemia with MLL gene rearrangements: outcome following intensive chemotherapy and hematopoietic stem cell transplantation. Blood 104:3527-3534, 2004.
8. Pui CH, Gaynon PS, Boyett JM, et al. Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region. Lancet 359:1909-1915, 2002.
9. De Braekeleer M, Morel F, Le Bris MJ, et al. The MLL gene and translocations involving chromosomal band 11q23 in acute leukemia. Anticancer Res 25:1931-1944, 2005.
10. Pui CH, Frankel LS, Carroll AJ, et al. Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia with the t(4;11)(q21;q23): a collaborative study of 40 cases. Blood 77:440-447, 1991.
11. Pui CH, Chessells JM, Camitta B, et al. Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements. Leukemia 17:700-706, 2003.
12. Pui CH, Crist WM, Look AT. Biology and clinical significance of cytogenetic abnormalities in childhood acute lymphoblastic leukemia. Blood 76:1449-1463, 1990.
13. Eguchi-Ishimae M, Eguchi M, Ishii E, et al. The association of a distinctive allele of NAD(P)H:quinone oxidoreductase with pediatric acute lymphoblastic leukemias with MLL fusion genes in Japan. Haematologica 90:1511-1515, 2005.
14. Smith MT, Wang Y, Skibola CF, et al. Low NAD(P)H:quinone oxidoreductase activity is associated with increased risk of leukemia with MLL translocations in infants and children. Blood 100:4590-4593, 2002.
15. Wiemels JL, Pagnamenta A, Taylor GM, et al. A lack of a functional NAD(P)H:quinone oxidoreductase allele is selectively associated with pediatric leukemias that have MLL fusions. United Kingdom Childhood Cancer Study Investigators. Cancer Res 59:4095-4099, 1999.